Clinical Trial Update: StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis [Phase 2]

View source ↗

Summary

A Phase 2b dose-finding study evaluating pravastatin as adjunctive therapy for tuberculosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• Pravastatin (pravastatin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis, Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2023-09-18